D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability
about
Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferaseINSM1 functions as a transcriptional repressor of the neuroD/beta2 gene through the recruitment of cyclin D1 and histone deacetylasesZinc finger transcription factor INSM1 interrupts cyclin D1 and CDK4 binding and induces cell cycle arrestIdentification of an INSM1-binding site in the insulin promoter: negative regulation of the insulin gene transcriptionRegulation of steroid hormone receptors and coregulators during the cell cycle highlights potential novel function in addition to roles as transcription factorsThe other side of the coin: the tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND-CDK4/6-RB axisProstatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epitheliumCell-cycle-dependent regulation of androgen receptor functionEnhanced expression of Pctk1, Tcf12 and Ccnd1 in hippocampus of rats: Impact on cognitive function, synaptic plasticity and pathologyARA67/PAT1 functions as a repressor to suppress androgen receptor transactivation.Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models.Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator.Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity.GCNF-dependent activation of cyclin D1 expression via repression of Mir302a during ESC differentiation.Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells.Tailoring to RB: tumour suppressor status and therapeutic response.SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms.Cyclin D3 promotes pancreatic β-cell fitness and viability in a cell cycle-independent manner and is targeted in autoimmune diabetes.Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function.The hematopoietic transcription factor AML1 (RUNX1) is negatively regulated by the cell cycle protein cyclin D3.Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulationCyclin D does not provide essential Cdk4-independent functions in Drosophila.Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function.Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functionsEvidence for CDK-dependent and CDK-independent functions of the murine gammaherpesvirus 68 v-cyclin.Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cellsTransgenic expression of cyclin-dependent kinase 4 results in epidermal hyperplasia, hypertrophy, and severe dermal fibrosis.Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neckConsequence of the tumor-associated conversion to cyclin D1bCyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia.Epigenetically altered miR-193b targets cyclin D1 in prostate cancerCell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitorsCyclin D3/CDK11p58 complex is involved in the repression of androgen receptor.CyclinD1 protein plays different roles in modulating chemoresponses in MCF7 and MDA-MB231 cellsConvergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.Integration of progesterone receptor action with rapid signaling events in breast cancer models.Cyclins, cyclin dependent kinases, and regulation of steroid receptor action.Cyclins and cell cycle control in cancer and disease.Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases.Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer.
P2860
Q24303548-46193EF6-2082-44FA-859F-5B4BC9A8C4E3Q24311334-03404F1F-1750-4046-B487-8221D0C7E340Q24313530-20D2685F-37BA-411C-9BD9-810F06BCBF0BQ24322398-74D7E5BE-CC8E-4D9A-9B2C-3BAA9C62FD99Q26771541-662B9D97-BD63-41D4-8F61-47F1129AAA27Q26865888-7FE44E47-FC49-4B00-8937-F17CDFFD1566Q28508802-D91F341D-667F-451C-982E-88FC518B28B1Q30300725-5DC424AE-81C8-436F-AD3C-0239C4109BFFQ30540950-4A6C2312-41D7-48CD-9CF7-FA122EFA8758Q30748653-12A79565-7AE6-4CC3-90E7-7B107411EDCFQ33428469-14C35E05-5BE8-4228-BE74-9C791C75325BQ33552193-DC60F6F5-1E36-4199-977E-8E9EB632F783Q33724440-05A3481C-5F98-4ECE-925B-FE0A38344086Q33881909-7C19FC2C-BA38-4A1A-8852-7218628BBC5CQ33936048-ACADA9AC-9B54-4A5E-898F-30FB88AF8335Q34040108-48203651-90CC-4A25-B2D6-DBE7E9A9186BQ34056043-C982D09D-9D29-4A82-BBAA-7D4CDD6C5B61Q34083001-E1E7FC6A-44F8-4ABC-B9B3-7065D1140466Q34125103-2EB5F589-4489-415C-B6AF-6A8A17230A70Q34150889-FB904096-4346-4057-A226-0DA900BA9431Q34478869-9BCB6B1B-1197-4788-A4AD-3747613CEC43Q34569850-B28D6CFC-8663-4D5A-A468-8E0C8A129094Q34624275-C1DDE114-F2C2-41F0-9297-D5BFF4E8AC46Q34958051-295C751C-344D-43AC-9222-23AEAD33C8A1Q35185875-507B768F-FA5E-46FA-86C3-5300E2E4BB95Q35221988-6D0D59A0-C52D-482E-9079-E9A5DA10A06CQ35746546-600DB581-2E84-4712-9BAF-CDA18C010F1AQ35788347-8F7F8EC1-EA04-47C0-89DC-58EEE8A6AD66Q35822584-ACD18325-41DA-4F4C-86DD-258C5D1EF20DQ35829500-3149B715-9233-4D03-AB57-056BD42C4B03Q36051801-6CE40FD0-F25F-49FA-B45B-B9F245EF3B6CQ36188773-37643F70-8B09-4200-A459-F08768B75A1BQ36315288-AF02766B-5FE7-40C3-AE5E-574EDB280AA1Q36451013-CAF497BC-1EB9-4AD7-B0CD-A616C9D7B892Q36497254-F641AF69-6129-4519-B806-1F55A7C064BFQ36580735-906732E6-B13B-4BFF-8E72-3469471A92CBQ36701285-E45ACB96-0E55-4019-BA60-7B5FCE059467Q36796438-6AE7CDFF-44B6-4476-8C48-65D356268E8BQ36827351-3E773FC1-8467-4ED4-898B-60C3AC92DF63Q37218223-A5B6FA67-A94D-45FD-8AF3-46D0F514E4E9
P2860
D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
D-type cyclins complex with th ...... tional transactivation ability
@ast
D-type cyclins complex with th ...... tional transactivation ability
@en
D-type cyclins complex with th ...... tional transactivation ability
@nl
type
label
D-type cyclins complex with th ...... tional transactivation ability
@ast
D-type cyclins complex with th ...... tional transactivation ability
@en
D-type cyclins complex with th ...... tional transactivation ability
@nl
prefLabel
D-type cyclins complex with th ...... tional transactivation ability
@ast
D-type cyclins complex with th ...... tional transactivation ability
@en
D-type cyclins complex with th ...... tional transactivation ability
@nl
P2093
P1433
P1476
D-type cyclins complex with th ...... tional transactivation ability
@en
P2093
K E Knudsen
W K Cavenee
P304
P407
P577
1999-05-15T00:00:00Z